Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Barbara White?

Barbara J. White

Chief Medical Officer

Corbus Pharmaceuticals Holdings Inc

HQ Phone:  (617) 963-0100

Direct Phone: (617) ***-****direct phone

Email: b***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Corbus Pharmaceuticals Holdings Inc

100 River Ridge Drive

Norwood, Massachusetts,02062

United States

Company Description

Corbus Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases. Our lead product candidate, Resunab™ ...more

Background Information

Employment History

Chief Marketing Officer

The Corbus LLC


Professor of Medicine and Vice Chair for Research, Department of Medicine

University of Maryland


Co-Director

Johns Hopkins University


Senior Vice President and Head of Research and Development

Stiefel Laboratories , Inc.


Roles

UCB S.A


Senior Director

MedImmune , Inc.


Affiliations

HOA

Board Member


American College of Rheumatology

Board Member


Food and Drug Administration

Ad Hoc Member of the Arthritis Advisory Committee


Education

University of Maryland


MD


medical degree

University of Pennsylvania School of Medicine


Web References(102 Total References)


Management Team :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD
Barbara White, MD Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.


Overview :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD
Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and View Full Bio


Management Team :: Corbus Pharmaceuticals Holdings, Inc. (CRBP)

ir.corbuspharma.com [cached]

Barbara White, MD
Barbara White, MD Chief Medical Officer Barbara White, M.D., joined Corbus as Chief Medical Officer in June 2014. Dr. White's industry experience includes Phase 1-4 clinical development experience in inflammatory and autoimmune diseases, including rheumatology, respiratory, and dermatology diseases. She also has industry experience in pre-clinical drug development, translational medicine and medical affairs. Prior to joining Corbus, Dr. White was Senior Vice President and Head of R&D at Stiefel, a GSK company. She has held roles at UCB, MedImmune and Amgen. Prior to her pharmaceutical career, Dr. White was professor of medicine and Vice Chair for Research, Department of Medicine, at the University of Maryland School of Medicine. Her research has focused on T cells and immune-mediated mechanisms of lung fibrosis in scleroderma. She also previously served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. Dr. White received her medical degree from the University of Pennsylvania School of Medicine and is board certified in internal medicine, rheumatology and allergy/clinical immunology. She completed her postdoctoral studies in basic cellular immunology at the National Institutes of Health.


Corbus Pharmaceuticals Reports Positive Topline Data Demonstrating Anabasum Reduces Acute Pulmonary Exacerbations and Multiple Inflammatory Biomarkers in Phase 2 Study in Patients with Cystic Fibrosis :: SternAegis Ventures

www.sternaegis.com [cached]

Barbara White, MD, Chief Medical Officer of Corbus, stated, "We are delighted that anabasum demonstrated a safety profile that was well tolerated by the CF patients in this study, especially given the challenges in safely targeting inflammation in CF. In a study of just 12-weeks of active dosing, we are especially encouraged by the consistency in data that couple clinical benefit in pulmonary exacerbations with improvement in the inflammatory response in the lungs.


Professional athletic trainers adopt sam® Sport to accelerate injury recovery and reduce opioid use for pain management - Boston Harbor Angels

www.bostonharborangels.com [cached]

Corbus CMO Dr. Barbara White, CEO Dr. Yuval Cohen and Dr. Michael Whitfield of Dartmouth University discuss the Phase...


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory